AmBisome gets expanded label

Gilead (GILD) and partner Fujisawa (Deerfield, Ill.) received FDA marketing approval for AmBisome amphotericin B for the treatment of cryptococcal meningitis in HIV-infected patients. Fujisawa submitt...